Day: July 2, 2026

Hong Kong Corporate News

Insilico Medicine and Takeda Announce Up to $600 Million AI-Powered Drug Discovery Collaboration 1

Minichart

July 2, 2026

InSilico Medicine Announces Strategic AI-Powered Drug Discov...

Continue Reading 0

Hong Kong Corporate News

Laekna, Inc. Announces HK$56 Million Share Repurchase and Senior Management Share Purchase Plan to Boost Shareholder Value 1

Minichart

July 2, 2026

Laekna, Inc. Announces Share Repurchase and Management Share...

Continue Reading 0

Hong Kong Corporate News

Suzhou Ribo Life Science Achieves First Milestone in siRNA Collaboration with Madrigal for MASH Liver Disease Treatment 1

Minichart

July 2, 2026

Suzhou Ribo Life Science Achieves First Milestone in Madriga...

Continue Reading 0

Hong Kong Corporate News

Abbisko Therapeutics and AstraZeneca Launch Phase II Clinical Trial of First-in-Class Oral PD-L1 Inhibitor Lumipodlin (ABSK043) with Tagrisso for EGFR-Mutated NSCLC 12

Minichart

July 2, 2026

Abbisko Therapeutics and AstraZeneca Announce Strategic Coll...

Continue Reading 0

Hong Kong Corporate News

Hangzhou SF Intra-city Announces H Share Incentive Scheme (2025) Share Purchases and Details

Minichart

July 2, 2026

Hangzhou SF Intra-city Industrial Co., Ltd. Share Purchase A...

Continue Reading 0

Hong Kong Corporate News

SSY Group Receives NMPA Approval for Methocarbamol Tablets and Phloroglucinol Dihydrate Product Development Update 1

Minichart

July 2, 2026

SSY Group Limited Announces Key Product Approvals in Mainlan...

Continue Reading 0

Hong Kong Corporate News

HSBC Holdings plc Announces PDMR Share Acquisitions from 2026 Interim Dividend Reinvestment

Minichart

July 2, 2026

HSBC Holdings plc – Notification of Transactions by PDMRs (J...

Continue Reading 0

Hong Kong Corporate News

Shanghai Bio-heart Receives NMPA Approval for Bioheart® Bioabsorbable Drug-Eluting Stents for Coronary Artery Disease Treatment 1

Minichart

July 2, 2026

Shanghai Bio-heart Biological Technology Co., Ltd. Announces...

Continue Reading 0

Hong Kong Corporate News

Venus Medtech Announces Potential RMB500 Million Investment Through New Shares and Convertible Bonds Subscription by Hangzhou Hi-Tech and Yingzhiqin 1

Minichart

July 2, 2026

Venus Medtech Announces Potential RMB500 Million Investment ...

Continue Reading 0

Hong Kong Corporate News

KANZHUN LIMITED (BOSS ZHIPIN-W) Hong Kong Listing: Waivers, Share Structure, Corporate Governance, and Key Company Information 2026

Minichart

July 2, 2026

Kanzhun Limited (BOSS Zhipin-W): Key Investor Updates from H...

Continue Reading 0